|
⚲
|
| Keyboard |
| Bell Margaret Smith
✚
|
|
|---|---|
| CIK # | 0001716713 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001716713] | |
| 4 | [0001716713] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bell Margaret Smith | |
| Tonix Pharmaceuticals Holding Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2025-05-13 | Grant | 10,000 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Common Stock, par value $0.001
|
2025-02-05 | Other | 1 | $0.15 | 0 |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2024-05-23 | Grant | 104,621 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2023-05-08 | Grant | 60,000 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2022-05-09 | Grant | 2,131,500 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2021-05-10 | Grant | 270,882 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Common Stock, par value $0.001
|
2020-08-20 | Buy | 5,391 | $0.93 | 5,014 |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2020-05-04 | Grant | 75,000 | $0.00 | |
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2019-05-06 | Grant | 30,000 | ||
|
Tonix Pharmaceuticals Holding Corp TNXP
Stock Option · derivative
|
2018-06-12 | Grant | 20,000 | $0.00 |